trending Market Intelligence /marketintelligence/en/news-insights/trending/dYVAfmlAvsimQvNPGYiSoQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Danaher posts 5.5% rise in Q3 EPS, narrows 2019 EPS guidance

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Danaher posts 5.5% rise in Q3 EPS, narrows 2019 EPS guidance

Danaher Corp.'s third-quarter adjusted net earnings per share rose 5.5% to $1.16 from $1.10 in the same period a year ago.

The S&P Global Market Intelligence consensus normalized EPS estimate for the third quarter was $1.15.

The medical-device maker's sales for the quarter increased by about 5%, to $5.04 billion, from $4.85 billion, in the third quarter of 2018.

On a GAAP-basis, Danaher's net earnings amounted to $648.4 million, or 89 cents per share, compared to $663.7 million, or 93 cents per share, in the year-ago period.

For the full year 2019, the company lowered its non-GAAP adjusted net EPS guidance range to $4.74 to $4.77, from the previous estimate of $4.75 to $4.80. GAAP EPS is expected to be in the range of $3.38 to $3.41, compared to the previous guidance of $3.38 to $3.43.

Danaher said the EPS guidance for the year takes into account the divestment of the 19.4% noncontrolling stake in its dental spin-off Envista Holdings Corp., which closed an IPO in September, raising about $643.4 million.

The S&P Global Market Intelligence consensus normalized EPS estimate for 2019 is $4.79.